Cue Biopharma to Present at Two March 2023 Investor Healthcare Conferences

On March 1, 2023 Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body, reported that it will take part in two investor healthcare conferences in March, the Cowen 43rd Annual Health Care Conference being held in Boston, Massachusetts March 6-8, 2023, and the Oppenheimer 33rd Annual Healthcare Conference being held virtually March 13-15, 2023 (Press release, Cue Biopharma, MAR 1, 2023, View Source [SID1234628008]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company will provide a corporate overview highlighting recent progress from their IL-2-based CUE-100 series of biologics. This will include discussions on its ongoing Phase 1 trials evaluating its lead drug candidate, CUE-101, in HPV+ recurrent/metastatic head and neck cancer as a monotherapy and in combination with pembrolizumab (KEYTRUDA), as well as their second clinical drug candidate, CUE-102, currently being evaluated in a Phase 1 trial for the treatment of Wilms’ Tumor 1 (WT1) positive cancers. The company will also discuss their newly established partnership with Ono Pharmaceutical to help advance Cue Biopharma’s lead autoimmune disease asset, CUE-401, toward the clinic.

Presentation Details:

Cowen 43rd Annual Health Care Conference
Date and Time: Tuesday, March 7 at 11:10 a.m. to 11:40 a.m. ET
Webcast Link: https://wsw.com/webcast/cowen132/cue/1835274
Presenter: Daniel Passeri, chief executive officer, Cue Biopharma

Oppenheimer 33rd Annual Healthcare Conference
Date and Time: Wednesday, March 15 at 12:00 p.m. to 12:30 p.m. ET
Webcast Link: View Source
Presenter: Daniel Passeri, chief executive officer, Cue Biopharma

Live and archived webcasts of the presentations will be available on the Events page in the Investors and Media section of the Company’s website at www.cuebiopharma.com. The webcasts will be archived for 30 days.